Cargando…
Maternal embryonic leucine zipper kinase is a novel target for proliferation-associated high-risk myeloma
Treatment of high-risk patients is a major challenge in multiple myeloma. This is especially true for patients assigned to the gene expression profiling-defined proliferation subgroup. Although recent efforts have identified some key players of proliferative myeloma, genetic interactions and players...
Autores principales: | Bolomsky, Arnold, Heusschen, Roy, Schlangen, Karin, Stangelberger, Kathrin, Muller, Joséphine, Schreiner, Wolfgang, Zojer, Niklas, Caers, Jo, Ludwig, Heinz |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Ferrata Storti Foundation
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5792277/ https://www.ncbi.nlm.nih.gov/pubmed/29122991 http://dx.doi.org/10.3324/haematol.2017.172973 |
Ejemplares similares
-
Maternal embryonic leucine zipper kinase inhibitor OTSSP167 has preclinical activity in multiple myeloma bone disease
por: Muller, Joséphine, et al.
Publicado: (2018) -
Targeting of BMI-1 with PTC-209 shows potent anti-myeloma activity and impairs the tumour microenvironment
por: Bolomsky, Arnold, et al.
Publicado: (2016) -
Synergistic interaction between HDAC and MCL-1 inhibitors through downregulation of BCL-XL in multiple myeloma
por: Schneller, Anja, et al.
Publicado: (2021) -
Structural Basis for the Regulation of Maternal Embryonic Leucine Zipper Kinase
por: Cao, Lu-Sha, et al.
Publicado: (2013) -
Stathmin involvement in the maternal embryonic leucine zipper kinase pathway in glioblastoma
por: Marie, Suely Kazue Nagahashi, et al.
Publicado: (2016)